Cambridge, MA · Founded 2022 · Privately Held (backing)
Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. Tasca Therapeutics is based in Cambridge, MA and was founded in 2022. It was valued at $83.3 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $67 million across 1 recorded round; the latest was a $48.1 million early-stage round in Nov 2024.
PMV mark · valuation
$83.3M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$67.0M
Last round
Early Stage VC
Nov 2024
Cap table — not yet on record
Tasca Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tasca Therapeutics with a free account
·Watch Tasca Therapeutics: the Monday email on marks, rounds and moves
Where does Tasca Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Tasca Therapeutics's 1 recorded funding rounds.
